Speakers

Dorothea Ledergerber

Chief Technical Officer • Tigen Pharma

Dorothea is a pharmacist with more than 20 years of experience in research, development, manufacturing and supply of pharmaceutical products. She received her PhD from the University of the Saarland, Saarbrücken, Germany.

While with Novartis, she led manufacturing sites in Switzerland, Germany and Ireland. A highlight in her career was the build-up and operational launch of the first commercial Cell & Gene manufacturing facility for Novartis in Europe.

In 2020, Dorothea moved on to Tigen Pharma, a Swiss biotech company in cell therapies to cure cancer. Tigen is a disruptive catalyst, combining a unique culture with a multidisciplinary set of clinical and technical capabilities and a long-term perspective to benefit patients and society. Dorothea is a firm believer in cross-cultural and -functional teams going beyond the beaten industry track.

Also speaking

Sarah Snykers

Senior Director of Operations Europe • Legend Biotech

Michael Cunniffe

Managing Director • Danforth Advisors

Jessica Berlier

Director P&AD • Catalent Cell & Gene Therapy

Event Info

Image

Sample Attendee List – 2024

Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
Image

Enquire to Sponsor/Exhibit

Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.